Oculis Holding AG (OCS) Financials
OCS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 140.8 million | 25.5 million |
| 2023-06-30 | 150.0 million | 19.6 million |
| 2023-03-31 | ? | ? |
| 2022-12-31 | 40.1 million | 146.1 million |
OCS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -13.1 million | 1.3 million |
| 2023-06-30 | ? | ? |
| 2023-03-31 | ? | ? |
| 2022-12-31 | -8.7 million | 156829 |
OCS Net Income
No data available :(
OCS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 116.4 million | - | 750366 |
| 2023-06-30 | 126.8 million | - | 796443 |
| 2023-03-31 | - | - | - |
| 2022-12-31 | 21.4 million | - | 684641 |
OCS Shares Outstanding
OCS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 20752 | 9.7 million | 4.0 million | - |
| 2023-06-30 | 13348 | 6.9 million | 4.8 million | - |
| 2023-03-31 | 13128 | - | - | - |
| 2022-12-31 | 1.6 million | 7.5 million | 2.0 million | - |
OCS Cost of Revenue
No data available :(
OCS
Price: $12.01
52 week price:
Earnings Per Share: -3.28 USD
P/E Ratio: -4.67
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 502.7 million